Edgardo Rivera

Medicine · Health Sciences

41h-index7.0kcitations87works4.82yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(42), HER2/EGFR in Cancer Research(20), Breast Cancer Treatment Studies(17), Chemotherapy-related skin toxicity(10), Colorectal Cancer Treatments and Studies(8)

Publications79 total

Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma
Journal of Clinical Oncology·2025· 4 cited
HSR25-200: Evaluation of a Patient Navigation System on Cancer Treatment Milestones in a Rural Cancer Center
Journal of the National Comprehensive Cancer Network·2025
A 15-Year-Old Boy with Abdominal Pain, Growth Retardation, and Anemia Secondary to <i>Helicobacter pylori–</i> associated Peptic Ulcer
Pediatric Annals·2015
Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
Cancer Chemotherapy and Pharmacology·2015· 158 citedOpen Access
A randomized, parallel-arm, phase II trial to assess the efficacy of preoperative ixabepilone with or without cetuximab in patients with triple-negative breast cancer (TNBC).
Journal of Clinical Oncology·2014· 4 cited
MP1-01 PERIURETHRALLY IMPLANTED AFFINITY-BASED CCL7 RELEASING HYDROGELS FOR STIMULATING STEM CELL MIGRATION IN STRESS URINARY INCONTINENCE
The Journal of Urology·2014
Affinity-Based Drug Delivery Devices and its Applications in the Modulation of Cellular Processes
OhioLink ETD Center (Ohio Library and Information Network)·2014Open Access
Eniluracil Plus 5-Fluorouracil and Leucovorin: Treatment for Metastatic Breast Cancer Patients in Whom Capecitabine Treatment Rapidly Failed
Clinical Breast Cancer·2013· 7 cited
Pilot study to assess toxicity and pharmacokinetics of docetaxel in patients with metastatic breast cancer and impaired liver function secondary to hepatic metastases
Journal of Oncology Pharmacy Practice·2013· 16 cited
Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients
Annals of Surgical Oncology·2012· 45 cited
Short-Term Biomarker Modulation Prevention Study of Anastrozole in Women at Increased Risk for Second Primary Breast Cancer
Cancer Prevention Research·2011· 6 cited
A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer
Cancer·2011· 25 citedOpen Access
Reconstrucción con aloprótesis de rodilla por navegación: reporte de un caso
2011
Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone
Breast Cancer Research·2010· 214 citedOpen Access
Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone
2010
Phase II Trial of Anastrozole Plus Goserelin in the Treatment of Hormone Receptor–Positive, Metastatic Carcinoma of the Breast in Premenopausal Women
Journal of Clinical Oncology·2010· 88 citedOpen Access
Implications of Anthracycline-Resistant and Taxane-Resistant Metastatic Breast Cancer and New Therapeutic Options
The Breast Journal·2010· 44 cited
Management of Metastatic Breast Cancer
American Journal of Clinical Oncology·2010· 40 cited
A phase 2 study of a fixed combination of uracil and ftorafur (UFT) and leucovorin given orally in a 3‐times‐daily regimen to treat patients with recurrent metastatic breast cancer
Cancer·2010· 7 citedOpen Access
Advances in neoadjuvant therapies for early breast cancer
Community Oncology·2009
page 1 of 4Next →

Frequent Co-authors

Gabriel N. Hortobágyi(26), Vicente Valero(25), Daniel J. Booser(14), Richard L. Theriault(11), Aman U. Buzdar(8), Massimo Cristofanilli(7), Nuhad K. Ibrahim(6), Bita Esmaeli(6), Francisco J. Esteva(6), Banu Arun(6), Lajos Pusztai(5), Debra Frye(4), Kristine Broglio(4), Zia Ur Rahman(4), Ronald S. Walters(4), Guosheng Yin(4), James L. Murray(4), Kelly K. Hunt(3), Eric A. Strom(3), Melanie Royce(3)